Quipt Home Medical (QIPT) Competitors $1.95 -0.19 (-8.88%) Closing price 04:00 PM EasternExtended Trading$1.94 -0.01 (-0.77%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock QIPT vs. TOI, AIRS, DCGO, EUDA, XGN, CORBF, ATPC, SERA, KDLY, and PIIIShould you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Oncology Institute (TOI), AirSculpt Technologies (AIRS), DocGo (DCGO), EUDA Health (EUDA), Exagen (XGN), Global Cord Blood (CORBF), Agape ATP (ATPC), Sera Prognostics (SERA), Kindly MD (KDLY), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Quipt Home Medical vs. Oncology Institute AirSculpt Technologies DocGo EUDA Health Exagen Global Cord Blood Agape ATP Sera Prognostics Kindly MD P3 Health Partners Quipt Home Medical (NASDAQ:QIPT) and Oncology Institute (NASDAQ:TOI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability. Do institutionals & insiders have more ownership in QIPT or TOI? 42.8% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 36.9% of Oncology Institute shares are owned by institutional investors. 13.4% of Quipt Home Medical shares are owned by insiders. Comparatively, 8.5% of Oncology Institute shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community favor QIPT or TOI? Quipt Home Medical received 27 more outperform votes than Oncology Institute when rated by MarketBeat users. Likewise, 82.05% of users gave Quipt Home Medical an outperform vote while only 71.43% of users gave Oncology Institute an outperform vote. CompanyUnderperformOutperformQuipt Home MedicalOutperform Votes3282.05% Underperform Votes717.95%Oncology InstituteOutperform Votes571.43% Underperform Votes228.57% Does the media favor QIPT or TOI? In the previous week, Oncology Institute had 1 more articles in the media than Quipt Home Medical. MarketBeat recorded 11 mentions for Oncology Institute and 10 mentions for Quipt Home Medical. Oncology Institute's average media sentiment score of 0.18 beat Quipt Home Medical's score of -0.40 indicating that Oncology Institute is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quipt Home Medical 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Oncology Institute 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend QIPT or TOI? Quipt Home Medical presently has a consensus target price of $2.85, suggesting a potential upside of 46.30%. Oncology Institute has a consensus target price of $7.00, suggesting a potential upside of 162.76%. Given Oncology Institute's higher possible upside, analysts plainly believe Oncology Institute is more favorable than Quipt Home Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quipt Home Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is QIPT or TOI more profitable? Quipt Home Medical has a net margin of -2.90% compared to Oncology Institute's net margin of -17.63%. Quipt Home Medical's return on equity of -6.70% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Quipt Home Medical-2.90% -6.70% -2.94% Oncology Institute -17.63%-186.83%-34.58% Which has more volatility and risk, QIPT or TOI? Quipt Home Medical has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500. Which has preferable valuation and earnings, QIPT or TOI? Quipt Home Medical has higher earnings, but lower revenue than Oncology Institute. Quipt Home Medical is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuipt Home Medical$240.85M0.35-$6.76M-$0.21-9.28Oncology Institute$403.15M0.50-$83.07M-$0.70-3.81 SummaryQuipt Home Medical beats Oncology Institute on 11 of the 17 factors compared between the two stocks. Get Quipt Home Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QIPT vs. The Competition Export to ExcelMetricQuipt Home Medicalhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$83.81M$2.06B$5.36B$8.40BDividend YieldN/A6.99%5.22%4.11%P/E Ratio-11.4416.1026.6219.74Price / Sales0.353.39391.30117.36Price / Cash2.569.3238.2534.62Price / Book0.793.966.804.51Net Income-$6.76M$87.49M$3.23B$248.18M7 Day Performance25.48%-8.00%4.02%1.07%1 Month Performance-3.23%-4.54%12.19%14.96%1 Year Performance-38.84%-29.37%17.04%6.70% Quipt Home Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QIPTQuipt Home Medical1.5576 of 5 stars$1.95-8.9%$2.85+46.2%-33.7%$84.03M$240.85M-11.47800News CoverageHigh Trading VolumeTOIOncology Institute2.2527 of 5 stars$3.06+2.3%$7.00+128.8%+355.7%$231.21M$393.41M-3.92660Earnings ReportGap UpAIRSAirSculpt Technologies0.4197 of 5 stars$3.56-0.3%$3.75+5.3%-11.6%$209.26M$172.10M-25.43240Gap UpDCGODocGo3.6871 of 5 stars$1.45-1.4%$3.56+145.5%-54.3%$147.88M$520.50M5.182,920EUDAEUDA HealthN/A$3.88+1.6%N/A+67.2%$144.15M$4.01M0.002XGNExagen4.5307 of 5 stars$6.33+5.3%$7.50+18.5%+218.7%$134.83M$56.72M-6.73220Analyst RevisionHigh Trading VolumeCORBFGlobal Cord BloodN/A$1.05-3.7%N/A-56.0%$127.63M$196.12M0.001,200ATPCAgape ATP0.4258 of 5 stars$2.03-1.0%N/A-57.0%$101.51M$1.32M-2.7840Earnings ReportSERASera Prognostics1.2261 of 5 stars$2.32+0.4%N/A-74.8%$87.38M$115,000.00-2.34120Positive NewsEarnings ReportKDLYKindly MD1.1004 of 5 stars$13.96+7.8%N/AN/A$84.07M$2.47M-18.13N/ANews CoverageGap UpPIIIP3 Health Partners2.2102 of 5 stars$7.94-0.6%$16.25+104.7%-70.6%$57.03M$1.50B-9.45500Earnings ReportGap Down Related Companies and Tools Related Companies Oncology Institute Alternatives AirSculpt Technologies Alternatives DocGo Alternatives EUDA Health Alternatives Exagen Alternatives Global Cord Blood Alternatives Agape ATP Alternatives Sera Prognostics Alternatives Kindly MD Alternatives P3 Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QIPT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quipt Home Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quipt Home Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QIPT Stock Free QIPT Stock Alerts